These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 20492502

  • 1. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis.
    Das K, Das K, Datta S, Pal S, Hembram JR, Dhali GK, Santra A, Chowdhury A.
    Liver Int; 2010 Aug; 30(7):1033-42. PubMed ID: 20492502
    [Abstract] [Full Text] [Related]

  • 2. Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites.
    Kim SU, Han KH, Nam CM, Park JY, Kim DY, Chon CY, Ahn SH.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1722-7. PubMed ID: 18717757
    [Abstract] [Full Text] [Related]

  • 3. The natural history of hepatitis B virus cirrhosis after the first hepatic decompensation in Tunisia.
    Jmaa A, Ksiaa M, Ben Slama A, Kahloun A, Jmaa R, Harrabi I, Golli L, Ajmi S.
    Tunis Med; 2012 Feb; 90(2):172-6. PubMed ID: 22407631
    [Abstract] [Full Text] [Related]

  • 4. Natural history of chronic hepatitis B virus infection: what determines prognosis after cirrhotic decompensation?
    Wei L.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1631-2. PubMed ID: 19120855
    [No Abstract] [Full Text] [Related]

  • 5. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W, Elsiesy H, Bendahmash A, Al-Masri N, Ali S, Allam N, Al Sofayan M, Al Bahili H, Al Sebayel M, Broering D, Saab S, Abaalkhail F.
    World J Gastroenterol; 2015 Jul 14; 21(26):8140-7. PubMed ID: 26185387
    [Abstract] [Full Text] [Related]

  • 6. Antiviral therapy delays esophageal variceal bleeding in hepatitis B virus-related cirrhosis.
    Li CZ, Cheng LF, Li QS, Wang ZQ, Yan JH.
    World J Gastroenterol; 2013 Oct 28; 19(40):6849-56. PubMed ID: 24187460
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization.
    Yoo SH, Jang JW, Kwon JH, Jung SM, Jang B, Choi JY.
    Clin Mol Hepatol; 2016 Dec 28; 22(4):458-465. PubMed ID: 28081589
    [Abstract] [Full Text] [Related]

  • 11. Natural history of compensated viral B and D cirrhosis.
    Gheorghe L, Iacob S, Simionov I, Vadan R, Gheorghe C, Iacob R, Parvulescu I, Constantinescu I.
    Rom J Gastroenterol; 2005 Dec 28; 14(4):329-35. PubMed ID: 16400347
    [Abstract] [Full Text] [Related]

  • 12. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group.
    Gastroenterology; 2007 Aug 28; 133(2):481-8. PubMed ID: 17681169
    [Abstract] [Full Text] [Related]

  • 13. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep 28; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.
    Orman ES, Roberts A, Ghabril M, Nephew L, Desai AP, Patidar K, Chalasani N.
    JAMA Netw Open; 2019 Jun 05; 2(6):e196412. PubMed ID: 31251379
    [Abstract] [Full Text] [Related]

  • 17. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.
    Bruno S, Saibeni S, Bagnardi V, Vandelli C, De Luca M, Felder M, Fracanzani AL, Prisco C, Vitaliani G, Simone L, Gaeta GB, Stanzione M, Persico M, Furlan C, Stroffolini T, Salerno F, Maisonneuve P, Almasio PL, AISF (Italian Association for the Study of the Liver) – EPA-SCO Collaborative Study Group.
    Am J Gastroenterol; 2013 Jul 05; 108(7):1112-22. PubMed ID: 23732467
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.